top of page

USPTO Allows Second U.S. Patent Application in Pavaka's Exclusively Licensed Ohio State Portfolio

Writer: Brent Toto
Brent Toto
Aug 11
2 min read

Updated: 7 days ago

COLUMBUS, Ohio — August 11, 2026 — The U.S. Patent and Trademark Office has issued a Notice of Allowance for U.S. Patent Application No. 18/819,379, titled "Antimicrobial Wound Care Dressing." The application is owned by the Ohio State Innovation Foundation and exclusively licensed to Pavaka Wound Care.


A Notice of Allowance means the patent examiner has completed review and concluded that the claims can be granted. The patent will formally issue after the remaining administrative steps, including payment of the issue fee.


Once issued, this will be the second U.S. patent in the Ohio State electroceutical wound dressing portfolio licensed to Pavaka. It joins U.S. Patent No. 12,102,508, issued in October 2024. The inventors are part of the Ohio State team, led by Mechanical and Aerospace Engineering Professor Shaurya Prakash, that developed the platform.


The licensed technology is a wound dressing that generates a low-level electric field at the wound surface. Pavaka is developing it as an investigational device for chronic and acute wounds, including those complicated by multidrug-resistant bacteria and biofilms.


The allowance strengthens a growing intellectual property position. Alongside the licensed Ohio State portfolio, Pavaka filed two U.S. provisional patent applications of its own in June 2026 covering next-generation designs. Together, the licensed Ohio State portfolio (one issued patent and one allowed application) and company-owned filings protect both the foundational platform and the improvements Pavaka is making as it moves toward manufacturing and regulatory review.


Pavaka thanks the Ohio State Innovation Foundation, Ohio State's Corporate Engagement & Commercialization team, the inventors and patent counsel for their work in prosecuting the application.


Ohio State's patent counsel prosecuted the application on behalf of the Ohio State Innovation Foundation. Patents in this portfolio are owned by the Foundation and licensed exclusively to Pavaka for commercialization.


"Each allowed claim makes the foundation under Pavaka stronger. We're grateful to Ohio State and its inventors for building such a robust portfolio, and we look forward to the formal issuance." — Frank Fischer, Chief Technology Officer and Co-Founder

Investigational device: Pavaka's electroceutical wound dressing has not been cleared or approved by the U.S. Food and Drug Administration and is not available for sale.


About Pavaka Wound Care: Pavaka Wound Care is a Columbus, Ohio–based medical device company developing an electroceutical advanced wound dressing for chronic and acute wounds, including wounds complicated by multidrug-resistant bacteria and biofilms. Built on technology exclusively licensed from The Ohio State University, the investigational dressing generates a low-level electric field at the wound surface. Pavaka was co-founded by CEO Brent Toto and CTO Frank Fischer. Learn more at www.pavakawoundcare.com.


Sources and further reading

Comments


bottom of page